Navigation
Market Outlook Stock Screener Dividend Calendar Event Calendar Rating of shares Markets News
Try free

Exact Sciences

NASDAQ EXAS
$53.51 -0.64 -1.20%
Today share price
USA
Sector: Healthcare Industry: Biotechnology
Get access
to the rating of Finrange stocks
With this tariff you will be able to use the service without restrictions, all information will be available
Get 7 days free

Rating Finrange

Index: 24 %
Market cap

Market capitalization – refers to the total value of all a company's shares of stock. It is calculated by multiplying the price of a stock by its total number of outstanding shares.

9.76B
EV

Enterprise value is a measure of a company's total value, often used as a more comprehensive alternative to equity market capitalization. Enterprise value includes in its calculation the market capitalization of a company but also short-term and long-term debt as well as any cash on the company's balance sheet.
11.55B
Beta

Beta is one of the most popular indicators of risk is a statistical measure. Analysts use this measure often when they need to determine a stock's risk profile.
1.31
Shares

Shares outstanding refer to a company's stock currently held by all its shareholders, including share blocks held by institutional investors and restricted shares owned by the company’s insiders.
182.35M
YTD

Year to date (YTD) refers to the period of time beginning the first day of the current calendar year or fiscal year up to the current date. he acronym often modifies concepts such as investment returns and price change.
-27.67 %

Upcoming events Exact Sciences

All events
No upcoming events scheduled

Overview

Financials

Key Metrics

Dividends

Industry overview

Events

Stock chart Exact Sciences

Stock analysis Exact Sciences

Indicator Company Industry
P/E (LTM)

Shows how many years the investor's investment in the company will pay off with a profit over the last 12 months.

More
-40.62 16.17
P/BV (LTM)

Shows the ratio of the market price of the share to the current book value.

More
3.10 4.32
EV/EBITDA (LTM)

Represents the ratio of the company's value to its pre-tax EBITDA in the last 12 months.

More
-341.54 8.89
Net Debt/EBITDA (LTM)

A company's debt ratio, which indicates how long the company will need to run on cash flow in the past 12 months to pay off its own debt.

More
-52.90 0.64
ROE (LTM)

Shows the efficiency of using the share capital by the company. In other words, ROE shows how much of the company's net profit for the invested capital over the last 12 months.

More
-7.67 4.05

Price change Exact Sciences per year

89.65$ 158.00$
Min Max

Summary analysis Exact Sciences

Get access
to the rating of Finrange stocks
With this tariff you will be able to use the service without restrictions, all information will be available
Get 7 days free

Shareholder structure Exact Sciences

Revenue and net income Exact Sciences

All parameters

Stock news Exact Sciences

All news
21 June 2023 в 15:20

Exact Sciences shares gain on results from non-invasive cancer screening test

21 June 2023 в 14:40

S&P 500 Futures Drop in Premarket Trading; Exact Sciences, Paramount Global Lead

9 January 2023 в 18:05

Cologuard Maker Exact Sciences Reports Big Sales and a Surprise Profit

9 January 2023 в 18:00

Cologuard Maker Exact Sciences Reports Big Sales and a Surprise Profit

16 December 2022 в 15:35

Premarket Movers: Exact Sciences, Adobe, Deckers Outdoor

16 December 2022 в 02:50

Stocks to Watch: Adobe, Agrify, Guardant Health, Exact Sciences

16 December 2022 в 02:50

Stocks to Watch: Adobe, Agrify, Guardant Health, Exact Sciences

16 December 2022 в 02:15

Guardant Health stock plunges, Exact Sciences stock soars after colorectal-cancer test study results

16 December 2022 в 01:35

Guardant Health stock plunges, Exact Sciences stock soars after colorectal-cancer test study results

30 September 2022 в 14:36

Premarket Movers: Nike Cl B, Exact Sciences, Olaplex

3 August 2022 в 20:01

Exact Sciences Stock Falls After Earnings. Here's What Wall Street Is Saying.

3 August 2022 в 19:56

Exact Sciences Stock Falls After Earnings. Here's What Wall Street Is Saying.

21 June 2022 в 13:21

Exact Sciences In Supply Deal With Ultima Genomics For Gene-Sequencing Technology

21 June 2022 в 13:21

Exact Sciences In Supply Deal With Ultima Genomics For Gene-Sequencing Technology

27 April 2022 в 16:45

How Exact Sciences Aims to Keep Its Lead in Cancer Tests

23 February 2022 в 17:41

Cancer-Test Maker Exact Sciences Saw Strong Revenue Growth

25 November 2021 в 17:50

Cathie Wood’s ARK Funds Bought Robinhood and Exact Sciences, Sold Tesla.

25 November 2021 в 17:50

Cathie Wood’s ARK Funds Bought Robinhood and Exact Sciences, Sold Tesla.

12 November 2021 в 14:40

Premarket Movers: Exact Sciences, Roivant Sciences, PagSeguro Digital

3 November 2021 в 16:21

Exact Sciences downgraded to outperform from strong buy at Raymond James

About company Exact Sciences

Exact Sciences Corporation provides cancer screening and diagnostic test products in the United States and internationally. The company offers Cologuard, a non-invasive stool-based DNA screening test to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer. It also provides Oncotype DX, a gene expression tests for breast, prostate, and colon cancers; Oncotype MAP, a tissue test delivering tumor profiling to aid therapy selection for patients with advanced, metastatic, refractory, or recurrent cancer; Oncotype DX AR-V7 Nucleus Detect Test, a liquid-based test for advanced stage prostate cancer; and Covid-19 testing services. The company's pipeline products focus on enhancing the Cologuard test's performance characteristics and developing blood and other fluid-based tests. It has license agreements with MAYO Foundation for Medical Education and Research; and Hologic, Inc. Exact Sciences Corporation was incorporated in 1995 and is headquartered in Madison, Wisconsin.
Address:
5505 Endeavor Lane, Madison, WI, United States, 53719
Company name: Exact Sciences
Issuer ticker: EXAS
ISIN: US30063P1057
Country: USA
Exchange: NASDAQ
Currency: $
IPO date: 2001-02-01
Sector: Healthcare
Industry: Biotechnology
Site: https://www.exactsciences.com

On which stock exchange are Exact Sciences (EXAS) stocks traded?

Exact Sciences (EXAS) stocks are traded on NASDAQ.

What is the ticker of Exact Sciences stocks (EXAS)?

The stock ticker of Exact Sciences’s stocks or in other words, the code is EXAS. The stocks are currently listed on the NASDAQ exchange.

In which sector and industry does Exact Sciences (EXAS) operate?

According to the GICS (Global Industry Classification Standard) classification developed jointly by MSCI and Standard & Poor's, Exact Sciences (EXAS) belongs to the «Healthcare» sector and the «Biotechnology» industry.

In what currency are Exact Sciences (EXAS) stocks traded?

Exact Sciences (EXAS) stocks are traded on the NASDAQ exchange in dollars.

What is the price of Exact Sciences (EXAS) stocks today?

The current price of Exact Sciences stocks on 13.05.2024 is 53.51 dollars. per share.

What is the dynamics of Exact Sciences (EXAS) stocks from the beginning of the year?

Exact Sciences (EXAS) quotes have increased by -27.46% from the beginning of the year up to 53.51 dollars. per 1 stocks.

How much did Exact Sciences (EXAS) stocks increase in мае 2024?

This month Exact Sciences (EXAS) quotes have increased by -10.83% to 53.51 dollars. per share.

How much are Exact Sciences (EXAS) stocks worth?

Today, on October, 13.05.2024 Exact Sciences’s (EXAS) stocks cost 53.51 dollars..

What is the market capitalization of Exact Sciences (EXAS)?

Capitalization is the market value of Exact Sciences (EXAS) is calculated as the number of issued stocks multiplied on the current quotation price. Thus, on 13.05.2024, the market capitalization of Exact Sciences (EXAS) is estimated at about 9757548500 dollars.